Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash from Operations (2016 - 2025)

Cumberland Pharmaceuticals' Cash from Operations history spans 16 years, with the latest figure at 3024.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 99.84% year-over-year to 3024.0; the TTM value through Dec 2025 reached 4932522.0, up 905.72%, while the annual FY2025 figure was 4932522.0, 905.72% up from the prior year.
  • Cash from Operations for Q4 2025 was 3024.0 at Cumberland Pharmaceuticals, down from 187180.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 3898517.0 in Q1 2025 and bottomed at 2136647.0 in Q1 2024.
  • The 5-year median for Cash from Operations is 475503.0 (2024), against an average of 923743.76.
  • The largest annual shift saw Cash from Operations surged 10601.79% in 2022 before it crashed 842.34% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 34642.0 in 2021, then soared by 10601.79% to 3638031.0 in 2022, then tumbled by 138.98% to 1418209.0 in 2023, then skyrocketed by 234.3% to 1904618.0 in 2024, then crashed by 99.84% to 3024.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Cash from Operations are 3024.0 (Q4 2025), 187180.0 (Q3 2025), and 843801.0 (Q2 2025).